All
Women's Dermatologic Society: New President Shares Hopes for Enduring Positive Change on Organization and Dermatology
Dermatology Times recently spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.
Rates, Incidence of Skin Cancer Found to be Higher in Patients With Skin of Color and in Rural Communities
Two posters at the AAD Annual Meeting examined disparities in skin cancer survival between urban and rural areas and assessed how having skin of color affects this.
Experts Develop Evidence and Consensus-Based Recommendations for Diagnosing and Treating Vitiligo in Young Patients
The recommendations were recently published in JAMA Dermatology following an extensive literature review, article grading, and a review of research questions.
AARS Responds to Valisure’s Data on Benzene in BPO Products
The statement said the petition came as a surprise to many ahead of AAD, and delves into the data complexity and patient considerations.
Skin Cancer and COVID-19: Research and Links Between Diagnosis and the Pandemic
We take a look at various studies examining the role of artificial intelligence in telemedicine photo quality, the impact of the COVID-19 pandemic and skin cancer diagnoses, and more.
Pointers With Portela: What is the Role of Vitamin A in Acne Treatment?
In this week’s Pointers With Portela, the 208SkinDoc dives into the efficacy and adverse effects of generic vitamin A to treat acne.
Dietary Interventions May Serve as Worthwhile Adjunct Therapy in Patients With Vitiligo
While additional, larger studies are necessary, researchers said dietary choices may help reduce dependency on pharmacological methods.
Consensus, Concern, and Commentary: Clinicians Share Thoughts on 'The BPO Bombshell'
We spoke with several dermatology experts to gauge their thoughts on Valisure's recent findings of benzene in benzoyl peroxide products--as well as what actions they plan to take moving forward.
Exciting Exosomes in Aesthetic Dermatology
In her March edition of Cosmetic Conundrums, Zoe Diana Draelos, MD, explores the role of exosomes in aesthetic dermatology, changes in the skin, and more.
Exploring the Link Between COVID-19 Research and Psoriatic Disease
We take a look at various studies exploring the relationship between psoriasis and COVID-19 vaccination, the link between COVID-19 and psoriasis severity, and more.
Artificial Intelligence Dermatology Mobile Apps Present Critical Risks and Inconsistencies, JAMA Study Reports
AI mobile apps have critical gaps in efficacy, safety, and transparency, according to a new report.
Robert Den, MD: Exploring the Potential of Alpha DaRT in Skin Cancer
Den, the chief medical officer of Alpha Tau, discusses the alpha particle-emitting atom treatment and its ability to target cancer cells without harming healthy tissue.
FDA Approves Boehringer Ingelheim's Spesolimab-sbzo For Adults and Children With Generalized Pustular Psoriasis
The expanded approval of Spevigo follows the Chinese National Medical Products Administration’s approval for the injection for the reduction of occurrence of GPP.
FDA Accepts Citius's Resubmitted BLA for Denileukin Diftitox for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
The FDA has assigned a Prescription Drug User Fee Act target action date for August 13.
Gender Disparities in Vitiligo: Psychological Effects and QoL
The social and psychological effects of vitiligo, particularly concerning gender disparities, have come to the forefront in recent literature.
Connecting COVID-19 Research to Impact on Patients With Atopic Dermatitis
Two recent studies delve into outcomes of pediatric populations with atopic conditions and an overview of patient outcomes utilizing a Mendelian randomization analysis.
Breaking Down Benzene Testing Methods of Benzoyl Peroxide Products
On March 6, 2024, Valisure, an independent testing laboratory, found high levels of benzene when BPO products were incubated at 37°C, 50°C, and 70°C.
Advocating for Mohs Surgery in Prison Populations
From our March cover feature: Vulnerable populations such as the prison population should have access to Mohs surgery to prevent the increased risk of morbidity and mortality from skin cancer.
FDA Accepts Journey Medical’s NDA for DFD-29 for Rosacea
The anticipated PDUFA date is November 4, 2024.
Reviewing Coverage of COVID-19- Related Research in Dermatology From the Past Year
It has been 4 years since the COVID-19 pandemic began. In the time since, there has been plentiful research regarding its implications in dermatology.
Poster Presentations Demonstrate Efficacy of Deuruxolitinib in Patients With Moderate to Severe Alopecia Areata
The data suggests that the medication, which targets specific cellular pathways, promotes hair regrowth in AA with minimal adverse effects.
Derm In The News: March 10-16
Keep up with the latest headlines in dermatology from the past week, including the AAD's vote to protect diversity, equity, and inclusion programs, a UK company's effort to democratize dermatologists’ services, and more.
The Weekly Roundup: March 11-15
ICYMI, this week we had news about AAD sessions and late-breaking research, the establishment of the very first annual National Dermatologist Day, benzene updates, and more.
Journal Digest: March 15
This week’s collection of the latest dermatologic studies covers the relationship between vitamin D receptor expression and cutaneous melanoma outcomes, efficacy of intravenous immunoglobulin in adults with treatment-resistant eosinophilic fasciitis, high dose oral isotretinoin versus low dose for cutaneous and genital warts, and the loss of integrity in the dermal-epidermal junction and hemidesmosomes during skin aging.
Arcutis Shares First Ever Research Revealing Gene Expression Profile of Seborrheic Dermatitis
The data was presented in a scientific session at the American Academy of Dermatology annual meeting.
Zoe Diana Draelos, MD, Offers Perspectives on Benzene and Benzoyl Peroxide
With 30 years of clinical dermatology research under her belt, Draelos responds to recent benzene and BPO news in this Q&A.
Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis Management
A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.
Tween Skin Care Mishaps via Misinformation on Social Media
Tween skin care has become a rising trend across social media platforms such as TikTok, and dermatology clinicians are becoming increasingly concerned about misinformation.
Timeline of Events: Benzene and Carbomer Regulation
Following Valisure’s Citizen’s Petition to the US Food and Drug Administration, we are recapping recent years of regulatory action regarding benzene and carbomers.
Addressing the Unique Skin Health Needs of LGBTQ+ Patients
A news release from the American Academy of Dermatology addressed skin-related issues that disproportionately affect LGBTQ+ individuals.